EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
Marksans' OTC Famotidine Tablets USP are acid reducers
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
Yinjia Biosciences will provide Porton Advanced with high-quality core protein raw materials and testing reagent products for quality control and evaluation systems.
Fluor is providing architectural and engineering services and procuring equipment for the new 275,000 square-foot manufacturing facility that will house two manufacturing lines to double manufacturing capability
According to GlobalData’s analyst consensus forecast, OTX-2002 is projected to have the highest revenue by 2028, with sales of $1.6 billion during that year
Subscribe To Our Newsletter & Stay Updated
